A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections
10.3341/jkos.2018.59.10.989
- Author:
Charm KIM
1
;
Kyung Seek CHOI
;
Hae Jung SUN
Author Information
1. Department of Ophthalmology, Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea. sunhj99@schmc.ac.kr
- Publication Type:Case Report
- Keywords:
Aflibercept;
Bevacizumab;
Choroidal osteoma;
Subretinal hemorrhage
- MeSH:
Adult;
Bevacizumab;
Choroid;
Choroidal Neovascularization;
Female;
Fluorescein Angiography;
Follow-Up Studies;
Hemorrhage;
Humans;
Intravitreal Injections;
Osteoma;
Recurrence;
Retinal Hemorrhage;
Retinaldehyde;
Tomography, Optical Coherence;
Ultrasonography;
Visual Acuity;
Visual Fields
- From:Journal of the Korean Ophthalmological Society
2018;59(10):989-994
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of choroidal osteoma (CO) complicated by extensive subretinal hemorrhage treated with intravitreal bevacizumab and aflibercept injections. CASE SUMMARY: A 42-year-old female patient presented with decreased visual acuity and a temporal visual field defect in the left eye. The patient had a history of retinal hemorrhage in the left eye 3 years prior, which improved without any treatment. The patient's visual acuity had decreased to 0.6 at the initial visit. On fundus examination, orange-colored elevated lesions involving the superior peripapillary area with massive subretinal hemorrhage extending to the macular area were revealed. Optical coherence tomography, fluorescein angiography, and B-scan ultrasonography results indicated CO complicated by choroidal neovascularization (CNV). With multiple intravitreal injections of bevacizumab and aflibercept (bevacizumab ×1, aflibercept ×2), the patient's visual acuity improved and the CNV lesion was kept stable without recurrence as of the 1-year follow-up visit. CONCLUSIONS: Intravitreal bevacizumab and aflibercept injections can be helpful in the treatment of CO complicated by CNV, by improving visual acuity and the retinal anatomy.